**Punjab and Haryana Ban Coldrif Cough Syrup Following Child Deaths in Madhya Pradesh**
Chandigarh: In the aftermath of the tragic deaths of 14 children reportedly linked to the consumption of Coldrif cough syrup in Madhya Pradesh, the states of Punjab and Haryana have imposed an immediate ban on the product.
The Punjab government issued an order on Monday stating that Coldrif syrup has been declared “not of standard quality” by the government analyst, drug testing laboratory, and the Food and Drugs Administration (FDA) of Madhya Pradesh.
The official order read, “Considering the seriousness of the matter, as the said product has been observed to be linked to the recent deaths of children in Chhindwara district, Madhya Pradesh, the above-mentioned product is hereby completely prohibited for sale, distribution, and utilisation in the state of Punjab with immediate effect in public interest.”
The directive further instructed all retailers, distributors, registered medical practitioners, and hospitals across Punjab not to purchase, sell, or use Coldrif cough syrup. It also urged anyone holding stock of the drug to report the information promptly to the FDA.
It is important to recall that the 14 child deaths in Madhya Pradesh were reportedly caused by the consumption of this particular cough syrup, which is manufactured in Tamil Nadu. Subsequent investigations revealed that the syrup was adulterated with diethylene glycol—a highly toxic substance that poses serious health risks.
Both Punjab and Haryana’s proactive measures aim to prevent similar tragedies and ensure public safety following this alarming development.
https://www.freepressjournal.in/india/punjab-haryana-ban-coldrif-syrup-after-deaths-in-mp